Literature DB >> 5756447

Studies on dihydrofolate reductase related to the drug sensitivity of microbial and neoplastic cells.

C A Nichol.   

Abstract

Mesh:

Substances:

Year:  1968        PMID: 5756447     DOI: 10.1016/0065-2571(68)90019-8

Source DB:  PubMed          Journal:  Adv Enzyme Regul        ISSN: 0065-2571


× No keyword cloud information.
  7 in total

1.  Dihydrofolate reductase in Pediococcus cerevisiae strains susceptible and resistant to amethopterin.

Authors:  F Mandelbaum-Shavit; N Grossowicz
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

2.  Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid.

Authors:  P Alberto; R Peytremann; R Medenica; M Beretta-Piccoli
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

3.  Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).

Authors:  R de Jager; D Dupont; J J Rodzynek; C Dorlet; G Lagrange
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

4.  Phase II clinical trial of DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine) and folinic acid (CF) in solid tumors.

Authors:  R de Jager; A Brugarolas; M Hansen
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  Cross resistance to esters of methotrexate in a doxorubicin-resistant subline of P388 murine leukemia.

Authors:  A Ramu; M Fridkin; R Steinherz
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

6.  Cross-resistance and collateral susceptibility to antifolic antimalarial compounds.

Authors:  C C Smith; C S Genther
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

7.  Carrier-mediated transport of folate in a mutant of Pediococcus cerevisiae.

Authors:  F Mandelbaum-Shavit; N Grossowicz
Journal:  J Bacteriol       Date:  1973-05       Impact factor: 3.490

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.